TAAR 6 and HSP-70 variations associated with bipolar disorder

Neuroscience Letters

Volumn 465, Issue 3, 2009, Pages 257-261

  Pae, Chi Un ^a,b   Drago, Antonio ^c   Mandelli, Laura ^c   De Ronchi, Diana ^c   Serretti, Alessandro ^c  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Association; Bipolar disorder; Gene; Heat shock proteins; Trace amine associated receptor

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; HEAT SHOCK PROTEIN 70; LITHIUM; LORAZEPAM; MOOD STABILIZER; RECEPTOR PROTEIN; TRACE AMINE ASSOCIATED RECEPTOR 6 PROTEIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE LOCATION; GENETIC VARIABILITY; GENOTYPE; HAMILTON ANXIETY SCALE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

ADULT; BIPOLAR DISORDER; CELL CYCLE PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HETEROZYGOTE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INCIDENCE; KOREA; LINKAGE (GENETICS); MALE; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 70349786299     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.09.025     Document Type: Article

References (52)

1. Atalay M., Oksala N., Lappalainen J., Laaksonen D.E., Sen C.K., and Roy S. Heat shock proteins in diabetes and wound healing. Curr Protein Pept Sci 10 (2009) 85-95
2. Bolhassani A., and Rafati S. Heat-shock proteins as powerful weapons in vaccine development. Expert Rev Vaccines 7 (2008) 1185-1199
3. Brundel B.J., Ke L., Dijkhuis A.J., Qi X., Shiroshita-Takeshita A., Nattel S., Henning R.H., and Kampinga H.H. Heat shock proteins as molecular targets for intervention in atrial fibrillation. Cardiovasc Res 78 (2008) 422-428
4. Bukau B., Weissman J., and Horwich A. Molecular chaperones and protein quality control. Cell 125 (2006) 443-451
5. Burchett S.A., and Hicks T.P. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79 (2006) 223-246
6. Coyle T.R., Kochunov P., Patel R.D., Nery F.G., Lancaster J.L., Mangin J.F., Riviere D., Pillow D.R., Davis G.J., Nicoletti M.A., Serap Monkul E., Fox P.T., and Soares J.C. Cortical sulci and bipolar disorder. Neuroreport 17 (2006) 1739-1742
7. Craddock N., O'Donovan M.C., and Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on... Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry 190 (2007) 200-203
8. Craddock N., and Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 186 (2005) 364-366
9. Danese A. Genetic opportunities for psychiatric epidemiology: on life stress and depression. Epidemiol Psichiatr Soc 17 (2008) 201-210
10. Davis B., and Boulton A. The trace amines and their acidic metabolites in depression--an overview. Prog Neuropsychopharmacol Biol Psychiatry 18 (1994) 17-45
11. Escamilla M.A., and Zavala J.M. Genetics of bipolar disorder. Dialogues Clin Neurosci 10 (2008) 141-152
12. Farrow T.F., Whitford T.J., Williams L.M., Gomes L., and Harris A.W. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58 (2005) 713-723
13. Faul F., Erdfelder E., Lang A.G., and Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39 (2007) 175-191
14. Fieve R.R. Lithium therapy at the millennium: a revolutionary drug used for 50 years faces competing options and possible demise. Bipolar Disord 1 (1999) 67-70
15. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 11 (2009) e22
16. Goodwin G.M., Martinez-Aran A., Glahn D.C., and Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 18 (2008) 787-793
17. W. Guy, ECDEU Assessment manual for psychopharmacology: revised, Rockville, MD, 1976, pp. 534-537.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
19. Hartl F.U. Molecular chaperones in cellular protein folding. Nature 381 (1996) 571-579
20. Hendrick J.P., and Hartl F.U. Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem 62 (1993) 349-384
21. Hu X., Oroszi G., Chun J., Smith T.L., Goldman D., and Schuckit M.A. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 29 (2005) 8-16
22. Jabbi M., Korf J., Ormel J., Kema I.P., and den Boer J.A. Investigating the molecular basis of major depressive disorder etiology: a functional convergent genetic approach. Ann N Y Acad Sci 1148 (2008) 42-56
23. Jacob M.S., and Presti D.E. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Med Hypotheses 64 (2005) 930-937
24. Keck Jr. P.E., Kessler R.C., and Ross R. Clinical and economic effects of unrecognized or inadequately treated bipolar disorder. J Psychiatr Pract 14 Suppl 2 (2008) 31-38
25. Kim J.J., Mandelli L., Lim S., Lim H.K., Kwon O.J., Pae C.U., Serretti A., Nimgaonkar V.L., Paik I.H., and Jun T.Y. Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258 (2008) 239-244
26. Laxman K.E., Lovibond K.S., and Hassan M.K. Impact of bipolar disorder in employed populations. Am J Manag Care 14 (2008) 757-764
27. Lindquist S., and Craig E.A. The heat-shock proteins. Annu Rev Genet 22 (1988) 631-677
28. Manji H.K., Moore G.J., and Chen G. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatry Suppl 41 (2001) s107-s119
29. McIntyre R.S., Muzina D.J., Kemp D.E., Blank D., Woldeyohannes H.O., Lofchy J., Soczynska J.K., Banik S., and Konarski J.Z. Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 10 (2008) 66-72
30. Pae C.U., Drago A., Kim J.J., Mandelli L., De Ronchi D., and Serretti A. The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic Inpatients. Neuropsychobiology 59 (2009) 135-141
31. Pae C.U., Drago A., Kim J.J., Patkar A.A., Jun T.Y., Lee C., Mandelli L., De Ronchi D., Paik I.H., and Serretti A. TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study. Eur Psychiatry 23 (2008) 390-395
32. Pae C.U., Mandelli L., Serretti A., Patkar A.A., Kim J.J., Lee C.U., Lee S.J., Lee C., De Ronchi D., and Paik I.H. Heat-shock protein-70 genes and response to antidepressants in major depression. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1006-1011
33. Pae C.U., Yu H.S., Amann D., Kim J.J., Lee C.U., Lee S.J., Jun T.Y., Lee C., Paik I.H., Patkar A.A., and Lerer B. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res 42 (2008) 35-40
34. Parcellier A., Gurbuxani S., Schmitt E., Solary E., and Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun 304 (2003) 505-512
35. Porteous D. Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new. Curr Opin Genet Dev 18 (2008) 229-234
36. Potash J.B., Zandi P.P., Willour V.L., Lan T.H., Huo Y., Avramopoulos D., Shugart Y.Y., MacKinnon D.F., Simpson S.G., McMahon F.J., DePaulo Jr. J.R., and McInnis M.G. Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 160 (2003) 680-686
37. Potkin S.G., Karoum F., Chuang L.W., Cannon-Spoor H.E., Phillips I., and Wyatt R.J. Phenylethylamine in paranoid chronic schizophrenia. Science 206 (1979) 470-471
38. Rajaiah R., and Moudgil K.D. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 8 (2009) 388-393
39. Sandler M., Ruthven C.R., Goodwin B.L., and Coppen A. Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. Clin Chim Acta 93 (1979) 169-171
40. Savitz J., and Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 33 (2009) 699-771
41. Serretti A., Calati R., Mandelli L., and De Ronchi D. Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 7 (2006) 1659-1669
42. Serretti A., Chiesa A., Calati R., Perna G., Bellodi L., and De Ronchi D. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol 24 (2009) 1-18
43. Serretti A., Kato M., De Ronchi D., and Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 12 (2007) 247-257
44. Serretti A., and Mandelli L. The genetics of bipolar disorder: genome 'hot regions,' genes, new potential candidates and future directions. Mol Psychiatry 13 (2008) 742-771
45. Soo E.T., Ng Y.K., Bay B.H., and Yip G.W. Heat shock proteins and neurodegenerative disorders. ScientificWorldJournal 8 (2008) 270-274
46. Soo E.T., Yip G.W., Lwin Z.M., Kumar S.D., and Bay B.H. Heat shock proteins as novel therapeutic targets in cancer. In Vivo 22 (2008) 311-315
47. Sullivan P.F. Spurious genetic associations. Biol Psychiatry 61 (2007) 1121-1126
48. Sullivan P.F., Eaves L.J., Kendler K.S., and Neale M.C. Genetic case-control association studies in neuropsychiatry. Arch Gen Psychiatry 58 (2001) 1015-1024
49. Toko H., Minamino T., and Komuro I. Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy. Trends Cardiovasc Med 18 (2008) 88-93
50. Voegeli T.S., Wintink A.J., Chen Y., and Currie R.W. Heat shock proteins 27 and 70 regulating angiotensin II-induced NF-kappaB: a possible connection to blood pressure control?. Appl Physiol Nutr Metab 33 (2008) 1042-1049
51. Watowich S.S., and Morimoto R.I. Complex regulation of heat shock- and glucose-responsive genes in human cells. Mol Cell Biol 8 (1988) 393-405
52. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435